Porphyria hepatic E80.2

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Group of porphyrin diseases, which are based on a disturbance of the liver cell function (multiple or malformation of porphyrins). The term "acute hepatic porphyria" is used to describe the potentially intermittent acute form. Acute hepatic porphyria may currently be in a clinically manifest phase, see also porphyria syndrome, acute. After spontaneous remission or therapy, the porphyria process is in a subclinical phase (latency phase). The stability of the latency phase depends on prophylactic measures, especially on avoiding porphyrinogenic provocation factors.

Classification
This section has been translated automatically.

Diagnosis
This section has been translated automatically.

The diagnosis of acute hepatic porphyria is confirmed by:
  • Determination of the two porphyrin precursors: delta-aminolevulinic acid, porphobilinogen.
  • Determination of porphyrins in urine.

Note(s)
This section has been translated automatically.

Main Prohibited and Allowed Medicines and Agents for Acute Hepatic Porphyria:

Literature
This section has been translated automatically.

  1. Doss MO et al. (2003) Arneistoistofficants in acute hepatic porphyria and recommendations for anesthesia. In: Red List 2003, online version, http://www.rote-liste.de/Online/texte/anhang/porhyrien.html

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 29.10.2020